NASDAQ:MRNA

Moderna Stock Insider Trading

Healthcare > Biotechnology

Buy MRNA

*Your capital is at risk

$61.00

+1.66 (+2.79%)

At Close: Jun 23, 2026

Moderna Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -14.49. In total, the insiders bought 1.3M and sold 188.65K MRNA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-14.49
● Buy	1.3M shares
● Sell	188.65K shares
75% Buy Activity Moderate Negative Correlation
Sell Signal Medium Confidence Feb 23, 2026 Analysis Breakdown: Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 15, 2026 Buy	Common Stock M-Exempt	Hoge Stephen President	CEO / President	37 226 Value: $712.9K
Jun 15, 2026 Sell	Common Stock S-Sale	Hoge Stephen President	CEO / President	53 336 Value: $2.74M
Jun 15, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Hoge Stephen President	CEO / President	37 226 Value: $712.9K
Jun 15, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Hoge Stephen President	CEO / President	16 110 Value: $308.5K
Jun 15, 2026 Buy	Common Stock M-Exempt	Hoge Stephen President	CEO / President	16 110 Value: $308.5K
Jun 05, 2026 Buy	Restricted Stock Units M-Exempt	Klinger Shannon Thyme Chief Legal Officer	Officer	11 798 Value: $559.7K
Jun 05, 2026 Buy	Common Stock M-Exempt	Klinger Shannon Thyme Chief Legal Officer	Officer	11 798 Value: $559.7K
Jun 05, 2026 Sell	Common Stock F-InKind	Klinger Shannon Thyme Chief Legal Officer	Officer	5 705 Value: $294.3K
Jun 05, 2026 Sell	Common Stock F-InKind	Mock James M Chief Financial Officer	C-Suite Officer	5 705 Value: $294.3K
Jun 05, 2026 Buy	Common Stock M-Exempt	Mock James M Chief Financial Officer	C-Suite Officer	11 798 Value: $559.7K
Jun 05, 2026 Buy	Restricted Stock Units M-Exempt	Mock James M Chief Financial Officer	C-Suite Officer	11 798 Value: $559.7K
Jun 04, 2026 Buy	Common Stock M-Exempt	Klinger Shannon Thyme Chief Legal Officer	Officer	3 471 Value: $107.5K
Jun 04, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Klinger Shannon Thyme Chief Legal Officer	Officer	3 471 Value: $107.5K
Jun 04, 2026 Sell	Common Stock S-Sale	Klinger Shannon Thyme Chief Legal Officer	Officer	3 471 Value: $173.6K
May 28, 2026 Buy	Common Stock M-Exempt	Hoge Stephen President	CEO / President	610 Value: $29.0K
May 28, 2026 Sell	Common Stock F-InKind	Hoge Stephen President	CEO / President	295 Value: $14.0K
May 28, 2026 Buy	Restricted Stock Units M-Exempt	Hoge Stephen President	CEO / President	610 Value: $29.0K
May 28, 2026 Buy	Restricted Stock Units M-Exempt	Mock James M Chief Financial Officer	C-Suite Officer	328 Value: $15.6K
May 28, 2026 Buy	Common Stock M-Exempt	Klinger Shannon Thyme Chief Legal Officer	Officer	328 Value: $15.6K
May 28, 2026 Sell	Common Stock F-InKind	Klinger Shannon Thyme Chief Legal Officer	Officer	159 Value: $8K
May 28, 2026 Sell	Common Stock F-InKind	Mock James M Chief Financial Officer	C-Suite Officer	159 Value: $8K
May 28, 2026 Buy	Restricted Stock Units M-Exempt	Klinger Shannon Thyme Chief Legal Officer	Officer	328 Value: $15.6K
May 28, 2026 Buy	Common Stock M-Exempt	Mock James M Chief Financial Officer	C-Suite Officer	328 Value: $15.6K
May 27, 2026 Sell	Common Stock F-InKind	Hoge Stephen President	CEO / President	695 Value: $32.7K
May 27, 2026 Buy	Restricted Stock Units M-Exempt	Hoge Stephen President	CEO / President	1 437 Value: $68.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MODERNA INC.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus...

Read Full Profile Here